Ma SL - Search Results

1

Ge FJ, Dai XY, Qiu Y, Liu XN, Zeng CM, Xu XY, Chen YD, Zhu H, He QJ, Gai RH, Ma SL, Chen XQ, Yang B. Ge FJ, et al. Among authors: ma sl. Acta Pharmacol Sin. 2024 Jun;45(6):1252-1263. doi: 10.1038/s41401-024-01230-x. Epub 2024 Feb 15. Acta Pharmacol Sin. 2024. PMID: 38360931

2

Rechallenge with gefitinib following severe drug-induced hepatotoxicity in a patient with advanced non-small cell lung cancer: A case report and literature review.

Chen X, Pan Y, Zhang S, Chen D, Yang S, Li X, Ma S. Chen X, et al. Oncol Lett. 2014 Mar;7(3):878-880. doi: 10.3892/ol.2013.1756. Epub 2013 Dec 11. Oncol Lett. 2014. PMID: 24527096 Free PMC article.

3

[Drug induced hepatotoxicity in targeted therapy for lung cancer].

Chen X, Yang S, Ma S. Chen X, et al. Zhongguo Fei Ai Za Zhi. 2014 Sep 20;17(9):685-8. doi: 10.3779/j.issn.1009-3419.2014.09.08. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25248711 Free PMC article. Review. Chinese.

4

Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.

Zhang J, Cao J, Ma S, Dong R, Meng W, Ying M, Weng Q, Chen Z, Ma J, Fang Q, He Q, Yang B. Zhang J, et al. Oncotarget. 2014 Oct 30;5(20):9664-77. doi: 10.18632/oncotarget.1856. Oncotarget. 2014. PMID: 25313135 Free PMC article.

5

Resistance of SMMC-7721 hepatoma cells to etoposide in hypoxia is reversed by VEGF inhibitor.

Shi S, Yuan C, Zhuang K, Liang G, Yao Z, Wang D, Weng Q, Cao J, Luo P, Zhu H, Ding L, Ma S. Shi S, et al. Mol Med Rep. 2015 May;11(5):3842-7. doi: 10.3892/mmr.2015.3217. Epub 2015 Jan 16. Mol Med Rep. 2015. PMID: 25607114

6

Autophagy protects against dasatinib-induced hepatotoxicity via p38 signaling.

Yang X, Wang J, Dai J, Shao J, Ma J, Chen C, Ma S, He Q, Luo P, Yang B. Yang X, et al. Oncotarget. 2015 Mar 20;6(8):6203-17. doi: 10.18632/oncotarget.3357. Oncotarget. 2015. PMID: 25749037 Free PMC article.

7

Impact of ABCG2 polymorphisms on the clinical outcome of TKIs therapy in Chinese advanced non-small-cell lung cancer patients.

Chen X, Chen D, Yang S, Ma R, Pan Y, Li X, Ma S. Chen X, et al. Cancer Cell Int. 2015 Apr 19;15:43. doi: 10.1186/s12935-015-0191-3. eCollection 2015. Cancer Cell Int. 2015. PMID: 25960692 Free PMC article.

8

Proteins associated with EGFR-TKIs resistance in patients with non-small cell lung cancer revealed by mass spectrometry.

Yang S, Chen X, Pan Y, Yu J, Li X, Ma S. Yang S, et al. Mol Med Rep. 2016 Nov;14(5):4823-4829. doi: 10.3892/mmr.2016.5823. Epub 2016 Oct 11. Mol Med Rep. 2016. PMID: 27748866

9

Capilliposide from Lysimachia capillipes inhibits AKT activation and restores gefitinib sensitivity in human non-small cell lung cancer cells with acquired gefitinib resistance.

Zhang SR, Xu YS, Jin E, Zhu LC, Xia B, Chen XF, Li FZ, Ma SL. Zhang SR, et al. Among authors: ma sl. Acta Pharmacol Sin. 2017 Jan;38(1):100-109. doi: 10.1038/aps.2016.116. Epub 2016 Nov 14. Acta Pharmacol Sin. 2017. PMID: 27840409 Free PMC article.

10

Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.

Zhang SR, Zhu LC, Jiang YP, Zhang J, Xu RJ, Xu YS, Xia B, Ma SL. Zhang SR, et al. Among authors: ma sl. Acta Pharmacol Sin. 2017 Feb;38(2):233-240. doi: 10.1038/aps.2016.107. Epub 2016 Nov 14. Acta Pharmacol Sin. 2017. PMID: 27840411 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

362 results

Search Page

Filters